Vaxcyte Inc (PCVX)

Aug 13, 2025

Vaxcyte Inc. Rebounds From Oversold Zone — Now WhatTriple Digit Growth Focused Trade Plan Reviewed - 선데이타임즈

Aug 13, 2025

Aug 13, 2025

Vaxcyte Reports Progress in Vaccine Development - TipRanks

Aug 13, 2025

Aug 08, 2025

Guggenheim lowers Vaxcyte stock price target to $116 on trial timeline shifts - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Vaxcyte’s Strategic Advancements and Financial Stability Justify Buy Rating - TipRanks

Aug 08, 2025

Aug 08, 2025

Pipeline Insight into Pneumococcal Disease Treatments: Sanofi, Alopexx, and Virometix Lead the Way - AInvest

Aug 08, 2025

Aug 07, 2025

Vaxcyte, Inc. shares fall 9.56% intraday after FDA interactions and Phase 3 clinical program finalization. - AInvest

Aug 07, 2025

Aug 07, 2025

Vaxcyte price target lowered to $50 from $85 at TD Cowen - TipRanks

Aug 07, 2025

Aug 07, 2025

Vaxcyte’s Strategic Adjustments and Optimized Trials Drive Buy Rating - TipRanks

Aug 07, 2025

Aug 07, 2025

Vaxcyte Q2 Loss Widens 11%, Ends Quarter with $2.83B in Cash - AInvest

Aug 07, 2025

Aug 07, 2025

Vaxcyte Q2 EPS $1.22, beats consensus $1.16; CEO discusses Phase 3 program for VAX-31. - AInvest

Aug 07, 2025

Aug 07, 2025

Vaxcyte (PCVX) Q2 Loss Widens 11% - AOL.com

Aug 07, 2025

Aug 06, 2025

Vaxcyte (PCVX) Q2 Loss Widens 11% - The Motley Fool

Aug 06, 2025

Aug 06, 2025

Promising Prospects for Vaxcyte’s VAX-31: Strong Adult Trial Results and Strategic Advancements in Infant Studies Reinforce Buy Rating - TipRanks

Aug 06, 2025

Aug 06, 2025

Vaxcyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025

Aug 06, 2025

Vaxcyte Reports Second Quarter 2025 Financial Results and - GlobeNewswire

Aug 06, 2025

Aug 06, 2025

Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) - Yahoo Finance

Aug 06, 2025

Aug 05, 2025

MACD Signals Flash Warning for Vaxcyte Inc. StockMulti-Bagger Potential Stock Forecast Tools Released - metal.it

Aug 05, 2025

Aug 03, 2025

What is the dividend policy of Vaxcyte Inc. stockStay ahead with advanced stock screening tools - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Vaxcyte Inc. company’s balance sheetUnprecedented profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Vaxcyte Inc. compare to its industry peersDiscover stocks with explosive upside potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Vaxcyte Inc. stock overvalued or undervaluedAchieve breakthrough performance in the market - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Vaxcyte Inc. a growth stock or a value stockFree Investment Risk Control - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Vaxcyte Inc. generate profit in a changing economyAchieve rapid financial growth with smart picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Vaxcyte Inc. stock expected to show significant growthUnlock powerful stock screening tools today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Vaxcyte Inc. stockDiscover stocks with explosive growth potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Vaxcyte Inc. stock priceInvest smarter with real-time trading signals - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Vaxcyte Inc.Stay ahead with advanced stock screening tools - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Vaxcyte Inc. in the next 12 monthsBuild a diversified portfolio for steady growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Vaxcyte Inc. stock in 2025Phenomenal capital appreciation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Vaxcyte Inc. stockPowerful profit generation - Jammu Links News

Aug 03, 2025

Aug 01, 2025

InvestingPro’s Fair Value model predicted Vaxcyte’s 46% decline By Investing.com - Investing.com

Aug 01, 2025

Jul 31, 2025

Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants - Yahoo Finance

Jul 31, 2025

Jul 31, 2025

What markets is Vaxcyte Inc. expanding into Is FDUS stock a good long term investment optionFree Stock Target Finder That Work - Jammu Links News

Jul 31, 2025

Jul 30, 2025

We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth - 富途牛牛

Jul 30, 2025

Jul 30, 2025

11 Best Future Stocks to Buy Now - Insider Monkey

Jul 30, 2025

Jul 28, 2025

What makes Vaxcyte Inc. stock price move sharplyMarket Entry and Exit Point Tips From Traders - metal.it

Jul 28, 2025

Jul 28, 2025

What is the risk reward ratio of investing in Vaxcyte Inc. stockInvest smarter with daily stock recommendations - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What catalysts could drive Vaxcyte Inc. stock higher in 2025Rapid growth trajectories - Jammu Links News

Jul 28, 2025